April 18, 2007 - AAEP is On Board !!!

Posted to EC List 4/18/2007 Msg #90405

Dear AAEP Members:

As you may be aware, the FDA has withdrawn the drug pergolide from
the market for use in humans. In order for the drug to continue to be
available for use in veterinary medicine, the FDA must approve an
exception for pergolide to be used by veterinarians and to be
compounded in bulk quantities.

The AAEP, through its Drug Compounding Task Force, has been in
contact with the FDA, and they are aware of the significant impact of
pergolide's withdrawal from the market on equine medicine. The FDA
Center for Veterinary Medicine is working with its counterpart for
human medicine, the Center for Drug Evaluation and Research, to allow
importation of pergolide for use by compounding pharmacies. The FDA
expects to have an official announcement by the end of this week.

The AAEP will continue to communicate with the FDA on this issue. For
updates, please visit the AAEP Web site at or call the AAEP office at
(800) 443-0177.

Sincerely,
The AAEP